Healthy Hepper Newsletter
- Healthy Hepper.com Newsletter
In this issue:
1. Potential Benefits of Licorice Root
2. Hepatitis Event: Teleconference for the hep C community
3. Hepatitis Information Page
1. Licorice Root
Licorice root is the peeled or unpeeled dried root of the licorice plant (Glycyrrhiza glabra).
The primary active component of licorice root is a substance called glycyrrhizin. Licorice
root has been in use in China since the second and third century B.C. and in the West
since Egyptian, Greek, and Roman times.21
Summary of the research findings
* Laboratory studies of glycyrrhizin in cell cultures suggest that it may have antiviral
* In a review of several randomized controlled trials, researchers reported that
glycyrrhizin has potential for reducing long-term complications in chronic hepatitis C in
those patients who may not respond to interferon.22 Several of the trials reviewed
indicated improvements in liver tissue damaged by hepatitis. Some also showed
improvements in how well the liver did its job after treatment.
* A 1997 study and a 2002 review suggest that long-term administration of glycyrrhizin
might prevent liver cancer in patients with chronic hepatitis C.23,24
* The use of glycyrrhizin as a complementary therapy (i.e., used in addition to
conventional interferon therapy) has been studied, but no significant benefit has been
* Recent clinical trials have shown that taking glycyrrhizin lowers the levels of liver
enzymes (increased levels of certain liver enzymes indicate liver damage or inflammation).
However, taking the herbA plant or part of a plant used for its flavor, scent, or potential
therapeutic properties. Includes flowers, leaves, bark, fruit, seeds, stems, and roots. did
not reduce the amount of HCV in patients' blood, a critical indicator of the long-term
progress of the infection.27-29
Side effects and possible risks
Taking licorice over a prolonged period of time can lead to potentially serious side effects,
including high blood pressure, salt and water retention, swelling, depletion of potassium,
headache, and/or sluggishness.30 Glycyrrhizin can worsen ascites, the accumulation of
fluid in the abdominal cavity, a condition that can be caused by cirrhosis.31 The herb also
can interact with certain drugs, such as diuretics, digitalis, antiarrhythmic agents, and
Information taken from:
2. Here is one great interactive event everyone can make it to. If you would like to check
out more hep events or if youd like one posted, vistit
Have questions? Join the Hepatitis C Teleconferences on Wednesday
Posted by: "PeachStatePam"
Join us every Wednesday from 7pm to 9pm CST, to listen to speakers discuss various
hepatitis C related topics, followed by a question and answer session, and time to "chat."
Teleconference is free and confidential. You are not required to give your "real" name, but
the moderator will ask the state you're calling from.
If you are a healthcare provider, or product sales person (pharmaceutical or the like), you
are required to disclose this information should you come into the discussion. This is a
teleconference for the hep C community, their family and friends. Please respect their
By the way, if you want to have an @... email address, send an email to
signup@..., and we'll set you up with one!!
JOHANNA KOSKINEN, HEPATITIS C MULTICULTURAL OUTREACH
PAM LANGFORD, H.E.A.L.S. of the South
If you'd like to join weekly chats,
send an email to:
Hep C Chat Live!!!
You will receive a telephone number and a code
to join the conference
The website to sign up and get the code is: http://www.hepcmo.org/chatlive.htm
3. Hepatitis Information
Read in depth on these topics at:
I. NUTRITIONAL HEALING
A. Nutritional Healing for Hep C
B. Amino Acids
E. Liver Herbs
F. Foods Good for the Liver
G. Thymic Protein
H. Alpha Lipoic Acid
I. Vitamin C & HCV
J. Milk Thistle - Silymarin
L. Nutritional Liver Supplements
II. HEP C FACTS & FAQ'S
Facts & FAQ's
III. WARNINGS FOR PEOPLE WITH HEP C
A. List of Potentially Harmful Substances
IV. NAOMI JUDD'S VICTORY
A. Judd's Victory Over Hepatitis
B. Letter From Naomi
C. Naomi's Holistic (Body-Mind-Spirit) Reading List
D. Naomi's Self-Directed Healing Program
E. Sound Healing & Audio Tape Suggestions from Naomi
A. LLOYD WRIGHT
B. Ralph Napolitano, "A Survivor's Story" CLICK HERE
VI. IMMUNE SYSTEM
Your Immune System & Hep C
VII. NEWLY DIAGNOSED WITH HEP C
Read in depth on these topics at:
- Healthy Hepper Newsletter: May 4, 2009
Exciting New Hep C Info:
1. New Website page on Hep and LDN
2. Drug means new era of treatment for hepatitis C
1. New Website page on Hep and LDN
Please visit http://www.healthyhepper.com/LDN.htm
to see the brand new web page created on LDN as alternative treatment for hepatitis.
"LDN may well be the most important therapeutic breakthrough in over fifty years. It provides a new method of medical treatment by mobilizing the natural defenses of one's own immune system." David Gluck, MD
2. Drug means new era of treatment' for hepatitis C
By SARAH AVERY
04/29/2009 09:57:36 PM EDT
RALEIGH, N.C. - A new drug appears to cure far more people of hepatitis C and does it in half the time of current therapies, researchers at Duke University report Thursday.
The drug is now in the final testing stages. If all goes well, it could be on the market in 2011.
"People believe this is a really significant improvement in how we'll be able to care for patients with hepatitis C," said Dr. John McHutchison, a Duke doctor who studies liver diseases and the lead investigator of the study, which is published in Thursday's New England Journal of Medicine.
The disease, spread by a virus in blood, is the leading cause of liver
transplants in the United States.
Many people who have hepatitis C have no symptoms for years and even decades.
They are diagnosed only when they begin suffering liver disease or the virus is detected in a blood test.
Currently, treatment cures about 41 percent of patients. And it is expensive, costing upwards of $20,000 for a full regimen.
It is also notoriously challenging. Patients must get weekly shots for nearly a year, plus take daily pills. Side effects are numerous and often debilitating -anxiety, depression, fatigue, headache, fever, poor appetite, dry mouth and sores, hair loss, nausea and chest pains.
"It's really devastating," said Ron Smith, 55, of Wilmington, N.C., who was diagnosed with the disease in 2001 and underwent treatment that he says made him feel like he had been hit with the flu for a year.
"It just unplugs the life out of you."
The new drug, called telaprevir, works by disabling the virus's ability to reproduce. It's designed to be used in conjunction with the current therapies,so patients would still face the potential side effects. But because it cuts the length of time on therapy to just six months, many more patients might stick with the treatments.
"That would help so many people," Smith said, noting that he has counseled numerous people who have had to drop out of treatment because they couldn't tolerate it.
"Obviously a lot of this stuff will impact overall quality of life and
relationships," said Tim Virgilio, a social worker at the Durham VA Medical Center who coordinates the hospital's hepatitis C support group.
Virgilio and others who work with hepatitis C patients said they were eager for a new drug and that the telaprevir therapy has been widely anticipated. Another drug that operates on the same principle is in the pipeline, but a report last fall indicated many people found it too harsh.
McHutchison at Duke said telaprevir also has side effects; it appears to worsen rashes and anemia associated with traditional therapies. Still, the drug is being welcomed as the brightest treatment prospect in years for hepatitis C.
An editorial in the New England Journal of Medicine calls telaprevir a "material advance in the therapy of hepatitis C, beginning a new era of treatment."
The last big breakthrough for the liver disease was in 2001, when the Food and Drug Administration approved a time-release formula of the antiviral drug interferon. That allowed patients to get weekly injections of the drug instead of three times a week.
Still, much remains to be determined. The telaprevir drug trial has enrolled 1,000 patients for the final Phase 3 study before FDA approval. And it's unknown how much it will add to the cost of already expensive therapies.
Susan Thompson, adult viral hepatitis prevention coordinator with the state Division of Public Health, said she hopes that by shortening the duration of treatment, the new drug could actually reduce costs.
Even if it doesn't, though, she said patients would welcome the prospect of cutting their treatment time in half.
Please visit our brand new page http://www.healthyhepper.com/LDN.htm
Subscribe to this newsletter at: